Latest filing published 03 Mar 2025 for Cyclo Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Francis Patrick Ostronic (board member) discloses dealings in Cyclo Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 29 October 2021 to 27 February 2025, the count stands at 27 filings.
The open-market record is one-sided, with 14 purchases worth €153k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 13 share grants.
Half of the purchases are above €7,037 and half below. On 12 out of 14 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
The latest filing, published on 3 March 2025, reports a share grant in Cyclo Therapeutics, Inc. The last purchase on record was published on 24 April 2023, which is 1,273 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 27 declarations